Synera Venipuncture Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

November 30, 2013

Conditions
PainPhlebotomyPalliative Care
Interventions
DRUG

Synera (lidocaine 70mg/tetracaine 70mg)

All subjects will receive 2 patch applications during this study: one Synera, one placebo. The 2 patch applications must be done on separate days. Only 1 patch will be used per application. Arm 1 subjects will receive Synera patch for the 1st application, and placebo for the second. Arm 2 patients will receive placebo patch for the 1st application, and Synera patch for the second.

Trial Locations (1)

Unknown

19 Locations Including, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nuvo Research Inc.

INDUSTRY

lead

US Oncology Research

INDUSTRY

NCT01744197 - Synera Venipuncture Pain | Biotech Hunter | Biotech Hunter